Ilika plc First Customer Shipment of Stereax(R) Batteries (6996V)
11 Avril 2023 - 8:00AM
UK Regulatory
TIDMIKA
RNS Number : 6996V
Ilika plc
11 April 2023
Ilika plc
("Ilika" or the "Company")
First Customer Shipment of Stereax(R) Batteries from UK
Manufacturing Facility
Ilika (AIM: IKA), a pioneer in solid-state battery technology,
announces it has made its first customer shipment of Stereax(R)
batteries from its UK manufacturing facility. This shipment is the
first of a series of planned deliveries to customers over the
coming months. The first shipment consists of a batch of single
layer Stereax(R) M50 cells, which Ilika has allocated to its
customer Blink Energy, the provider of device-agnostic power and
communications platforms for any ocular device. The M50 cells can
be used individually, but they are also the building blocks for
Ilika's M300 batteries, which are constructed from six M50 cells
connected in parallel. Forthcoming Stereax(R) customer deliveries
will also include M300 batteries.
The ultra-thin profile of M50 cells is of particular benefit to
Blink Energy, which is designing products to power and connect
smart ocular devices. Blink Energy's aim is to resolve unmet needs
of patient compliance, reliability, connectivity, and pricing of
the smart contact lens market. Blink Energy's solution, Blink
IT(TM) (a smart patch device), fits onto the eyelid epicanthal
fold, and contains a designated power and communication platform
that wirelessly connects a smart lens to a mobile app.
Further to Ilika's announcement of 16 January 2023, Ilika and
Cirtec Medical LLC ('Cirtec'), a strategic outsourcing partner of
complex medical devices including minimally invasive and active
implantable devices, are currently finalising the terms of their
intended partnership. Ilika and Cirtec have signed a memorandum of
understanding ('MOU') which outlines the transfer of Stereax(R)
mm-scale battery manufacturing to Cirtec's facility in Lowell,
Massachusetts, U.S. Following the transfer, Ilika will focus on
advanced technology development and IP licensing in support of
Cirtec's manufacturing and commercialisation activities.
Graeme Purdy, Ilika's Chief Executive Officer said: "We are
delighted to have begun fulfilling our commitments to customers by
shipping batteries from our UK facility. Starting with Blink
Energy, we look forward to further supporting our customers'
product roadmaps for miniature medical devices and industrial IoT
applications. Our relationship with Cirtec will further support
commercial ramp-up in due course".
Yariv Bar-on, Blink Energy co-founder and Chief Executive
Officer, commented: " We are looking forward with great
anticipation to the arrival of the first batch of Ilika's
Stereax(R) cells. These are miniature batteries that offer the
optimal form factor and power density necessary to power and
facilitate communication for Blink's platform of smart ocular
devices. As we continue to develop our product offerings, we
eagerly anticipate evaluating the Stereax(R) cells to determine
their potential impact."
For more information contact:
Ilika plc www.ilika.com
Graeme Purdy, Chief Executive Via Walbrook PR
Liberum Capital Limited (Nomad Tel: 020 3100 2000
and Joint Broker)
Andrew Godber,
William Hall, Nikhil Varghese
Joh. Berenberg, Gossler & Co. KG Tel: 020 3207 8700
(Joint Broker)
Matthew Armitt, Mark Whitmore, Detlir
Elezi,
Mara Grasso
Walbrook PR Ltd Tel: 020 7933 8780 / Ilika@walbrookpr.com
Lianne Applegarth Mob: 07584 391 303
Nick Rome Mob: 07748 325 236
Tom Cooper Mob: 07971 221 972
About Ilika Technologies
Ilika specializes in the development of solid-state batteries.
Its Stereax(R) product line is designed for miniature medical
implants and specialist internet of Things (IoT) applications.
Stereax(R) enables disruptive product designers looking for an
intrinsically safe, long life (1000s recharges), low leakage (nA)
and miniature power source in a rectangular form factor similar to
ICs. For more information about Ilika, please visit:
https://www.ilika.com.
About Blink Energy
Blink Energy is located in Haifa, Israel. Blink's
ground-breaking and patented technology accelerates the adoption of
intelligent ocular devices, reducing their time-to-market and total
cost of ownership, with a minimal footprint. For further
information please visit: https://www.blinkenrg.com/
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCFLFVRSSIRIIV
(END) Dow Jones Newswires
April 11, 2023 02:00 ET (06:00 GMT)
Ilika (AQSE:IKA.GB)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Ilika (AQSE:IKA.GB)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024